These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19580676)

  • 1. Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults.
    Chow TW; Mamo DC; Uchida H; Graff-Guerrero A; Houle S; Smith GS; Pollock BG; Mulsant BH
    BMC Med Imaging; 2009 Jul; 9():12. PubMed ID: 19580676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging.
    Kapur S; Jones C; DaSilva J; Wilson A; Houle S
    Nucl Med Commun; 1997 May; 18(5):395-9. PubMed ID: 9194079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametric PET imaging of 5HT2A receptor distribution with 18F-setoperone in the normal human neocortex.
    Petit-Taboué MC; Landeau B; Barré L; Onfroy MC; Noël MH; Baron JC
    J Nucl Med; 1999 Jan; 40(1):25-32. PubMed ID: 9935052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
    Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
    Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
    J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.
    Riaño Barros DA; McGinnity CJ; Rosso L; Heckemann RA; Howes OD; Brooks DJ; Duncan JS; Turkheimer FE; Koepp MJ; Hammers A
    Neuroimage; 2014 Aug; 97():151-62. PubMed ID: 24736184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-cerebrospinal fluid and blood-brain barriers imaged by 18F-labeled metabolites of 18F-setoperone studied in humans using positron emission tomography.
    Blin J; Crouzel C
    J Neurochem; 1992 Jun; 58(6):2303-10. PubMed ID: 1573409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.
    Blin J; Baron JC; Dubois B; Crouzel C; Fiorelli M; Attar-Lévy D; Pillon B; Fournier D; Vidailhet M; Agid Y
    Brain; 1993 Jun; 116 ( Pt 3)():497-510. PubMed ID: 8513389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
    Naganawa M; Waterhouse RN; Nabulsi N; Lin SF; Labaree D; Ropchan J; Tarabar S; DeMartinis N; Ogden A; Banerjee A; Huang Y; Carson RE
    J Nucl Med; 2016 Sep; 57(9):1388-95. PubMed ID: 27103022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone.
    Yatham LN; Liddle PF; Dennie J; Shiah IS; Adam MJ; Lane CJ; Lam RW; Ruth TJ
    Arch Gen Psychiatry; 1999 Aug; 56(8):705-11. PubMed ID: 10435604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET.
    Trichard C; Paillère-Martinot ML; Attar-Levy D; Blin J; Feline A; Martinot JL
    Schizophr Res; 1998 May; 31(1):13-7. PubMed ID: 9633832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and.
    Soares JC; van Dyck CH; Tan P; Zoghbi SS; Garg P; Soufer R; Baldwin RM; Fujita M; Staley JK; Fu X; Amici L; Seibyl J; Innis RB
    Psychiatry Res; 2001 Apr; 106(2):81-93. PubMed ID: 11306248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.
    Catafau AM; Pérez V; Penengo MM; Bullich S; Danús M; Puigdemont D; Pascual JC; Corripio I; Llop J; Perich J; Alvarez E
    J Nucl Med; 2005 Aug; 46(8):1301-9. PubMed ID: 16085586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia.
    Verhoeff NP; Meyer JH; Kecojevic A; Hussey D; Lewis R; Tauscher J; Zipursky RB; Kapur S
    Psychiatry Res; 2000 Oct; 99(3):123-35. PubMed ID: 11068194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone.
    Ngan ET; Yatham LN; Ruth TJ; Liddle PF
    Am J Psychiatry; 2000 Jun; 157(6):1016-8. PubMed ID: 10831488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.